AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025)
AbCellera Biologics filings provide 3 years of Construction in Progress readings, the most recent being $2.2 million for Q4 2025.
- Quarterly Construction in Progress fell 84.72% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 84.72% year-over-year, with the annual reading at $2.2 million for FY2025, 84.72% down from the prior year.
- Construction in Progress hit $2.2 million in Q4 2025 for AbCellera Biologics, down from $118.7 million in the prior quarter.
- Across five years, Construction in Progress topped out at $118.7 million in Q3 2025 and bottomed at $2.2 million in Q4 2025.
- Average Construction in Progress over 3 years is $23.4 million, with a median of $14.4 million recorded in 2024.
- Peak annual rise in Construction in Progress hit 670.78% in 2025, while the deepest fall reached 84.72% in 2025.
- AbCellera Biologics' Construction in Progress stood at $13.7 million in 2023, then rose by 5.11% to $14.4 million in 2024, then tumbled by 84.72% to $2.2 million in 2025.
- Per Business Quant, the three most recent readings for ABCL's Construction in Progress are $2.2 million (Q4 2025), $118.7 million (Q3 2025), and $23.1 million (Q2 2025).